These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 33201300

  • 1. Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience.
    Alghisi A, Borghetti P, Maddalo M, Roccaro AM, Tucci A, Mazzola R, Magrini SM, Lo Casto A, Bonù ML, Tomasini D, Pasinetti N, Peretto G, Bertagna F, Tomasi C, Buglione M, Triggiani L.
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1773-1779. PubMed ID: 33201300
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients.
    Ozsahin M, Tsang RW, Poortmans P, Belkacémi Y, Bolla M, Dinçbas FO, Landmann C, Castelain B, Buijsen J, Curschmann J, Kadish SP, Kowalczyk A, Anacak Y, Hammer J, Nguyen TD, Studer G, Cooper R, Sengöz M, Scandolaro L, Zouhair A.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):210-7. PubMed ID: 16229966
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.
    Knobel D, Zouhair A, Tsang RW, Poortmans P, Belkacémi Y, Bolla M, Oner FD, Landmann C, Castelain B, Ozsahin M, Rare Cancer Network.
    BMC Cancer; 2006 May 05; 6():118. PubMed ID: 16677383
    [Abstract] [Full Text] [Related]

  • 5. Radiotherapy Alone is Associated with Improved Outcomes Over Surgery in the Management of Solitary Plasmacytoma.
    Li QW, Niu SQ, Wang HY, Wen G, Li YY, Xia YF, Zhang YJ.
    Asian Pac J Cancer Prev; 2015 May 05; 16(9):3741-5. PubMed ID: 25987031
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh CO, Mauch PM, Specht L, Yahalom J.
    Int J Radiat Oncol Biol Phys; 2018 Jul 15; 101(4):794-808. PubMed ID: 29976492
    [Abstract] [Full Text] [Related]

  • 9. Radiotherapy of solitary plasmacytoma.
    Krause S, Hillengass J, Goldschmidt H, Debus J, Neuhof D.
    Ann Hematol; 2011 Sep 15; 90(9):1093-7. PubMed ID: 21336625
    [Abstract] [Full Text] [Related]

  • 10. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
    Dimopoulos MA, Moulopoulos A, Delasalle K, Alexanian R.
    Hematol Oncol Clin North Am; 1992 Apr 15; 6(2):359-69. PubMed ID: 1582978
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors.
    Suh YG, Suh CO, Kim JS, Kim SJ, Pyun HO, Cho J.
    Ann Hematol; 2012 Nov 15; 91(11):1785-93. PubMed ID: 22752147
    [Abstract] [Full Text] [Related]

  • 13. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma.
    Kilciksiz S, Karakoyun-Celik O, Agaoglu FY, Haydaroglu A.
    ScientificWorldJournal; 2012 Nov 15; 2012():895765. PubMed ID: 22654647
    [Abstract] [Full Text] [Related]

  • 14. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome.
    Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, Stewart AK.
    Int J Radiat Oncol Biol Phys; 2001 May 01; 50(1):113-20. PubMed ID: 11316553
    [Abstract] [Full Text] [Related]

  • 15. Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy.
    Reed V, Shah J, Medeiros LJ, Ha CS, Mazloom A, Weber DM, Arzu IY, Orlowski RZ, Thomas SK, Shihadeh F, Alexanian R, Dabaja BS.
    Cancer; 2011 Oct 01; 117(19):4468-74. PubMed ID: 21437886
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party.
    Kilciksiz S, Celik OK, Pak Y, Demiral AN, Pehlivan M, Orhan O, Tokatli F, Agaoglu F, Zincircioglu B, Atasoy BM, Ozseker N, Yersal O, Niang U, Haydaroglu A, Turkish Oncology Group-Sarcoma Working Party.
    Am J Hematol; 2008 Sep 01; 83(9):702-7. PubMed ID: 18543343
    [Abstract] [Full Text] [Related]

  • 18. Solitary plasmacytoma of bone and soft tissues.
    Tong D, Griffin TW, Laramore GE, Kurtz JM, Russell AH, Groudine MT, Herron T, Blasko JC, Tesh DW.
    Radiology; 1980 Apr 01; 135(1):195-8. PubMed ID: 7360960
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
    Wilder RB, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R.
    Cancer; 2002 Mar 01; 94(5):1532-7. PubMed ID: 11920511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.